Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

BACKGROUND: No specific antiviral drug has been proven effective for treatment of patients with severe coronavirus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside analogue prodrug, has inhibitory effects on pathogenic animal and human coronaviruses, including severe acute respiratory syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yeming, Zhang, Dingyu, Du, Guanhua, Du, Ronghui, Zhao, Jianping, Jin, Yang, Fu, Shouzhi, Gao, Ling, Cheng, Zhenshun, Lu, Qiaofa, Hu, Yi, Luo, Guangwei, Wang, Ke, Lu, Yang, Li, Huadong, Wang, Shuzhen, Ruan, Shunan, Yang, Chengqing, Mei, Chunlin, Wang, Yi, Ding, Dan, Wu, Feng, Tang, Xin, Ye, Xianzhi, Ye, Yingchun, Liu, Bing, Yang, Jie, Yin, Wen, Wang, Aili, Fan, Guohui, Zhou, Fei, Liu, Zhibo, Gu, Xiaoying, Xu, Jiuyang, Shang, Lianhan, Zhang, Yi, Cao, Lianjun, Guo, Tingting, Wan, Yan, Qin, Hong, Jiang, Yushen, Jaki, Thomas, Hayden, Frederick G, Horby, Peter W, Cao, Bin, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190303/
https://www.ncbi.nlm.nih.gov/pubmed/32423584
http://dx.doi.org/10.1016/S0140-6736(20)31022-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190303/
https://www.ncbi.nlm.nih.gov/pubmed/32423584
http://dx.doi.org/10.1016/S0140-6736(20)31022-9

Ejemplares similares